[Successful immunosuppressive treatment of a pancytopathy with positive LE phenomenon induced by ethosuccinimide].
D000741:Anemia, Aplastic / Q000139:chemically induced / Q000188:drug therapy*; D000974:Antibodies, Antinuclear; D000941:Antigens; D000963:Antimetabolites; D001323:Autoantibodies; D001379:Azathioprine / Q000627:therapeutic use*; D002675:Child, Preschool; D004247:DNA / Q000378:metabolism; D004827:Epilepsy / Q000188:drug therapy; D005013:Ethosuximide / Q000009:adverse effects*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D009504:Neutrophils
D000974:Antibodies, Antinuclear; D000941:Antigens; D000963:Antimetabolites; D001323:Autoantibodies; D005013:Ethosuximide; D004247:DNA; D001379:Azathioprine
Erfolgreiche immunsuppressive Behandlung einer Pancytopathie mit positivem LE-Phänomen, induziert durch Ethosuccinimid.